Ranitidine

Product NDC: 55111-131
11-digit product format: 551110131
Labeler code: 55111
Product ID: 55111-131_210e3c0b-be93-aa50-550d-e383e7d5f19e
Type: HUMAN OTC DRUG
Nonproprietary name: Ranitidine
Dosage form: TABLET
Route: ORAL
Labeler: Dr. Reddy's Laboratories Limited
Application: ANDA075294
Marketing category: ANDA
Marketing start: 2000-03-01
Substance: RANITIDINE HYDROCHLORIDE
Active strength: 75 mg/1
Pharmacologic classes: Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
NDC exclude flag: No
Listing certified through: 2026-12-31
Current FDA listing: Yes

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 77 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-04	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-90	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-79	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-80	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-14	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-37	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-30	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-45	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	55111-131-81	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-04	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-90	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-79	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-80	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-14	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-37	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-30	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-45	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	55111-131-81	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-04	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-90	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-79	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-80	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-14	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-37	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-30	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-45	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	55111-131-81	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-04	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-90	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-79	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-80	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-14	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-37	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-30	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-45	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	55111-131-81	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-45	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-81	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-90	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-79	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-80	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-30	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-04	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-37	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-60	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	55111-131-14	U	Excluded because listing certification expired	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55111-131-45	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55111-131-81	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55111-131-90	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	55111-131-79	U	Excluded because listing certification expired	`ed331223b511…`	`672a5bd82f5f…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A075294-001	RANITIDINE HYDROCHLORIDE	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL			2000-03-28

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 2 · 42 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`301d65b070ca…`
2024-06-18 03:08 UTC · 5 captures of this ZIP	2024-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`1e350fbaab3a…`
2024-05-31 18:47 UTC	2024-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`8072bd15b7f6…`
2022-06-29 02:47 UTC · 2 captures of this ZIP	2022-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5c6f7cd8ea54…`
2022-04-08 23:34 UTC	2022-04	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5d02ea3f76ae…`
2022-04-04 05:41 UTC	2022-04	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`4b0b4de00fa7…`
2019-12-13 00:20 UTC	2019-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`74a2ff9319b5…`
2022-03-09 01:35 UTC	2022-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`bb7c543d1eb4…`
2021-12-28 21:50 UTC	2021-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`782e0a99824c…`
2021-05-05 16:15 UTC · 3 captures of this ZIP	2021-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`87673890dc5c…`
2021-03-12 10:30 UTC	2021-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`5aa47cf7b7d7…`
2020-12-22 03:56 UTC	2020-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`8869cabd3fbd…`
2020-11-12 02:37 UTC	2020-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`c0c555d07b60…`
2019-12-14 00:12 UTC	2019-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3f01610625f2…`
2019-09-15 20:21 UTC	2019-09	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`b00525d2431f…`
2019-07-19 19:46 UTC	2019-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`ea99ee380514…`
2024-03-16 18:09 UTC · 4 captures of this ZIP	2024-03	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`6a51e52b5d6a…`
2024-02-18 07:12 UTC	2024-02	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`1c564ffb4f44…`
2023-12-20 04:57 UTC	2023-12	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`ea1830bbd6c7…`
2023-11-28 05:40 UTC · 2 captures of this ZIP	2023-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`a72a2bbeb626…`
2023-10-25 00:34 UTC · 2 captures of this ZIP	2023-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`9b2671bbb829…`
2023-07-15 15:27 UTC · 2 captures of this ZIP	2023-07	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`a67488948f0b…`
2023-06-13 01:57 UTC · 3 captures of this ZIP	2023-06	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3f0d92c62455…`
2023-05-13 08:27 UTC	2023-05	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`053a50430f4f…`
2023-01-26 05:58 UTC	2023-01	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3bdfa0b2c4d7…`
2022-11-12 20:34 UTC · 5 captures of this ZIP	2022-11	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`3a93d1ddd44b…`
2022-10-28 04:53 UTC	2022-10	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`f41ea6bd6efb…`
2022-09-29 23:25 UTC	2022-09	A075294-001	RANITIDINE HYDROCHLORIDE	EQ 75MG BASE	TABLET / ORAL	2000-03-28	`e64feba35796…`

Additional Listing Data#

Finished product: Yes
Brand name base: Ranitidine
Listing expiration: 2026-12-31

Active Ingredients#

Ingredient, Strength table
Ingredient	Strength
RANITIDINE HYDROCHLORIDE	75 mg/1

Harmonized UNII identifiers#

UNII identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
BK76465IHM	Internal UNII lookup

Harmonized RxCUI identifiers#

RxCUI identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
312773	Internal RxNorm lookup

Harmonized SPL set identifiers#

SPL set identifiers page 1 of 1 · 1 matching rows.

Identifier, FDA.report destination table
Identifier	FDA.report destination
12a38e29-130c-6d41-1753-acccb0b41efe	Available on FDA.report

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
7f54af34-be54-4c3c-894f-78df6452d747	Product name	3	20190703
ccf8541e-b7dc-e6ba-06c9-15bf143a7850	Product name	5	20190611
05700d9e-ea6f-4aab-b0ed-1488f1d85d7b	Product name	1	20180904
2f9d4e5c-e179-490e-8c43-f19e1e0ca228	Product name	1	20160720

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
55111-131-04	2025-05-27	Drug Facts
55111-131-14	2025-05-27	Drug Facts
55111-131-30	2025-05-27	Drug Facts
55111-131-37	2025-05-27	Drug Facts
55111-131-45	2025-05-27	Drug Facts
55111-131-60	2025-05-27	Drug Facts
55111-131-79	2025-05-27	Drug Facts
55111-131-80	2025-05-27	Drug Facts
55111-131-81	2025-05-27	Drug Facts
55111-131-90	2025-05-27	Drug Facts
55111-131-04	2025-01-30	Drug Facts
55111-131-14	2025-01-30	Drug Facts
55111-131-30	2025-01-30	Drug Facts
55111-131-37	2025-01-30	Drug Facts
55111-131-45	2025-01-30	Drug Facts
55111-131-60	2025-01-30	Drug Facts
55111-131-79	2025-01-30	Drug Facts
55111-131-80	2025-01-30	Drug Facts
55111-131-81	2025-01-30	Drug Facts
55111-131-90	2025-01-30	Drug Facts

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
55111-131-60	EA - Each	55111-131	0f78e0cf-e93c-462a-ac98-19f5df909814	1	2018-12-13

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
CETIRIZINE HYDROCHLORIDE	ACTIVE INGREDIENT	64O047KTOA	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
CETIRIZINE	ACTIVE MOIETY	YO7261ME24	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
ranitidine	ACTIVE MOIETY	884KT10YB7	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
LACTOSE MONOHYDRATE	INACTIVE INGREDIENT	EWQ57Q8I5X	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
POLYETHYLENE GLYCOL 400	INACTIVE INGREDIENT	B697894SGQ	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
POVIDONE	INACTIVE INGREDIENT	FZ989GH94E	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
STARCH, CORN	INACTIVE INGREDIENT	O8232NY3SJ	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	6
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	ALLERGY RELIEF (CETIRIZINE HYDROCHLORIDE TABLETS) TABLET, FILM COATED [WAL-MART STORES INC]	6
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
ranitidine	ACTIVE MOIETY	884KT10YB7	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	WAL-ZAN 75 (RANITIDINE TABLET USP, 75MG) TABLET [WALGREENS COMPANY]	2
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
ranitidine hydrochloride	ACTIVE INGREDIENT	BK76465IHM	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
ranitidine	ACTIVE MOIETY	884KT10YB7	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
ranitidine	ACTIVE MOIETY	884KT10YB7	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
ranitidine	ACTIVE MOIETY	884KT10YB7	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
cellulose, microcrystalline	INACTIVE INGREDIENT	OP1R32D61U	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
ferrosoferric oxide	INACTIVE INGREDIENT	XM0M87F357	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
HYPROMELLOSES	INACTIVE INGREDIENT	3NXW29V3WO	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
magnesium stearate	INACTIVE INGREDIENT	70097M6I30	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
Polyethylene Glycols	INACTIVE INGREDIENT	3WJQ0SDW1A	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	RANITIDINE 75 (RANITIDINE TABLETS) TABLET [MEIJER DISTRIBUTION INC]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [THE KROGER CO.]	1
titanium dioxide	INACTIVE INGREDIENT	15FIX9V2JP	RANITIDINE 75 (RANITIDINE TABLETS USP, 75MG) TABLET [TARGET BRANDS INC]	1

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
55111-131	RANITIDINE TABLET [DR. REDDY'S LABORATORIES LIMITED]	11	Current NDC, Legacy NDC	20250529_12a38e29-130c-6d41-1753-acccb0b41efe.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Ranitidine	RANITIDINE	Dr. Reddy's Laboratories Limited	12a38e29-130c-6d41-1753-acccb0b41efe	2025-05-23	Warnings	Exact identifier application applno (ANDA): 075294 application number: ANDA075294 ndc (product): 55111-131

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
BK76465IHM	RANITIDINE HYDROCHLORIDE	66357-59-3	RANITIDINE HYDROCHLORIDE
884KT10YB7	RANITIDINE	66357-35-5	Ranitidine

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
312773	ranitidine 75 MG Oral Tablet	PSN	12a38e29-130c-6d41-1753-acccb0b41efe	11
312773	ranitidine 75 MG Oral Tablet	SCD	12a38e29-130c-6d41-1753-acccb0b41efe	11
312773	ranitidine 75 MG (as ranitidine hydrochloride 84 MG) Oral Tablet	SY	12a38e29-130c-6d41-1753-acccb0b41efe	11

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
55111-131-04	55111013104	1 BOTTLE in 1 CARTON (55111-131-04) / 120 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-14	55111013114	2 BLISTER PACK in 1 CARTON (55111-131-14) / 10 TABLET in 1 BLISTER PACK	2 blister pack	2000-03-01	0000-00-00	No	No	Current
55111-131-30	55111013130	1 BOTTLE in 1 CARTON (55111-131-30) / 30 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-37	55111013137	1 BOTTLE in 1 CARTON (55111-131-37) / 160 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-45	55111013145	1 BOTTLE in 1 CARTON (55111-131-45) / 45 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-60	55111013160	1 BOTTLE in 1 CARTON (55111-131-60) / 60 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-79	55111013179	1 BLISTER PACK in 1 CARTON (55111-131-79) / 10 TABLET in 1 BLISTER PACK	1 blister pack	2000-03-01	0000-00-00	No	No	Current
55111-131-80	55111013180	1 BOTTLE in 1 CARTON (55111-131-80) / 80 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current
55111-131-81	55111013181	3 BLISTER PACK in 1 CARTON (55111-131-81) / 10 TABLET in 1 BLISTER PACK	3 blister pack	2000-03-01	0000-00-00	No	No	Current
55111-131-90	55111013190	1 BOTTLE in 1 CARTON (55111-131-90) / 90 TABLET in 1 BOTTLE	1 bottle	2000-03-01	0000-00-00	No	No	Current

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Drug Facts	Dr. Reddy's Laboratories Limited	2025-05-23	HUMAN OTC DRUG LABEL	11
Drug Facts	The Kroger Co.	2019-09-30	HUMAN OTC DRUG LABEL	5
Drug Facts	CVS HEALTH CORP	2019-09-30	HUMAN OTC DRUG LABEL	4
Drug Facts	Walgreens Company	2019-09-30	HUMAN OTC DRUG LABEL	4
Drug Facts	Chain Drug Marketing Association	2019-09-30	HUMAN OTC DRUG LABEL	3
Drug Facts	MAJOR PHARMACEUTICALS	2019-09-30	HUMAN OTC DRUG LABEL	3
Drug Facts	Meijer Distribution Inc	2017-12-07	HUMAN OTC DRUG LABEL	3
Cetirizine Hydrochloride Tablets	Wal-Mart Stores Inc	2014-05-09	HUMAN OTC DRUG LABEL	6
Drug Facts	Target Brands Inc	2014-01-29	HUMAN OTC DRUG LABEL	1